Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.
Biello F, Platini F, D'Avanzo F, Cattrini C, Mennitto A, Genestroni S, Martini V, Marzullo P, Aimaretti G, Gennari A. Biello F, et al. Among authors: mennitto a. Biomolecules. 2021 Jan 19;11(1):125. doi: 10.3390/biom11010125. Biomolecules. 2021. PMID: 33477996 Free PMC article. Review.
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
Borgogna C, De Andrea M, Griffante G, Lai A, Bergna A, Galli M, Zehender G, Castello L, Ravanini P, Cattrini C, Mennitto A, Gennari A, Gariglio M. Borgogna C, et al. Among authors: mennitto a. J Med Virol. 2021 Dec;93(12):6444-6446. doi: 10.1002/jmv.27200. Epub 2021 Jul 20. J Med Virol. 2021. PMID: 34260066 Free PMC article. No abstract available.
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Roviello G, Buti S, Cattrini C, Mennitto A, Messina C, Airoldi C, Vannini G, Bersanelli M. Roviello G, et al. Among authors: mennitto a. Ther Adv Urol. 2021 Jul 8;13:17562872211029784. doi: 10.1177/17562872211029784. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 34290828 Free PMC article. No abstract available.
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
Stellato M, Procopio G, De Giorgi U, Maruzzo M, Bimbatti D, Mennitto A, Sbrana A, Roviello G, Casadei C, Sepe P, Pignata S, Santini D. Stellato M, et al. Among authors: mennitto a. J Transl Med. 2021 Aug 3;19(1):328. doi: 10.1186/s12967-021-03008-9. J Transl Med. 2021. PMID: 34344414 Free PMC article.
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21).
Mennitto A, Zattarin E, Di Maio M, Bimbatti D, De Giorgi U, Buti S, Santini D, Casadei C, Sorarù M, Messina C, Mucciarini C, Di Lorenzo G, Roviello G, Buttigliero C, Stellato M, Sepe P, Claps M, Guadalupi V, Ottini A, Pignata S, De Braud FG, Verzoni E, Procopio G. Mennitto A, et al. Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 Nov 29. Expert Rev Anticancer Ther. 2022. PMID: 34738499
64 results